Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease

被引:4
|
作者
Lip, Gregory Y. H. [1 ,2 ,3 ,4 ]
机构
[1] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[2] Liverpool John Moores Univ, Liverpool, Merseyside, England
[3] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[4] Aalborg Univ, Dept Clin Med, Aalborg, Denmark
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 387卷 / 11期
关键词
ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULANTS; RHYTHM SOCIETY; METAANALYSIS; ASSOCIATION; GUIDELINES; WARFARIN; SAFETY; STROKE;
D O I
10.1056/NEJMe2210187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1036 / 1038
页数:3
相关论文
共 50 条
  • [1] Oral anticoagulation for atrial fibrillation in rheumatic heart disease
    Dougherty, Scott
    Nascimento, Bruno
    Okello, Emmy
    EUROPEAN HEART JOURNAL, 2023, 44 (27) : 2440 - 2442
  • [2] Atrial Fibrillation in Rheumatic Heart Disease
    Bansal, Ankit
    Sarkar, Prattay Guha
    Chaturvedi, Vivek
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2020, 22 (11)
  • [3] Atrial Fibrillation in Rheumatic Heart Disease
    Ankit Bansal
    Prattay Guha Sarkar
    Vivek Chaturvedi
    Current Treatment Options in Cardiovascular Medicine, 2020, 22
  • [4] Anticoagulation in Atrial Fibrillation With Valvular Heart Disease
    Fonseca, Ana Catarina
    Jorge, Claudia
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (04):
  • [5] A STUDY OF ATRIAL FIBRILLATION IN RHEUMATIC HEART DISEASE
    Boddu, Jyotirmayi
    Reddy, V. C. Srinivas
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (08): : 1020 - 1023
  • [6] Management of atrial fibrillation in rheumatic heart disease
    Shenthar, Jayaprakash
    HEART RHYTHM O2, 2022, 3 (06): : 752 - 759
  • [7] Management of atrial fibrillation in rheumatic valvular heart disease
    Vora, A
    CURRENT OPINION IN CARDIOLOGY, 2006, 21 (01) : 47 - 50
  • [8] Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation
    Connolly, S. J.
    Karthikeyan, G.
    Ntsekhe, M.
    Haileamlak, A.
    El Sayed, A.
    El Ghamrawy, A.
    Damasceno, A.
    Avezum, A.
    Dans, A. M. L.
    Gitura, B.
    Hu, D.
    Kamanzi, E. R.
    Maklady, F.
    Fana, G.
    Gonzalez-Hermosillo, J. A.
    Musuku, J.
    Kazmi, K.
    Zuhlke, L.
    Gondwe, L.
    Ma, C.
    Paniagua, M.
    Ogah, O. S.
    Molefe-Baikai, O. J.
    Lwabi, P.
    Chillo, P.
    Sharma, S. K.
    Cabral, T. T. J.
    Tarhuni, W. M.
    Benz, A.
    van Eikels, M.
    Krol, A.
    Pattath, D.
    Balasubramanian, K.
    Rangarajan, S.
    Ramasundarahettige, C.
    Mayosi, B.
    Yusuf, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 978 - 988
  • [9] Anticoagulation in atrial fibrillation with heart failure
    Lei Zhao
    William Y. S. Wang
    Xinchun Yang
    Heart Failure Reviews, 2018, 23 : 563 - 571
  • [10] Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease
    Diker, E
    Aydogdu, S
    Ozdemir, M
    Kural, T
    Polat, K
    Cehreli, S
    Erdogan, A
    Gokel, S
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (01): : 96 - 98